Building trust and diversity in patient-centered oncology clinical trials: An integrated model
2017
Background/aims:Trust is the cornerstone of clinical trial recruitment and retention. Efforts to decrease barriers and increase clinical trial participation among diverse populations have yielded modest results. There is an urgent need to better understand the complex interactions between trust and clinical trial participation. The process of trust-building has been a focus of intense research in the business community. Yet, little has been published about trust in oncology clinical trials or the process of building trust in clinical trials. Both clinical trials and business share common dimensions. Business strategies for building trust may be transferable to the clinical trial setting. This study was conducted to understand and utilize contemporary thinking about building trust to develop an Integrated Model of Trust that incorporates both clinical and business perspectives.Methods:A key word–directed literature search of the PubMed, Medline, Cochrane, and Google Search databases for entries dated betwe...
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
50
References
12
Citations
NaN
KQI